Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma
The article describes the experience in effective use of the second-generation EGFR II blocker in palliative target therapy of EGFRnegative lung adenocarcinoma. The use of afatinib in the fifth-line palliative therapy of EGFR-negative lung adenocarcinoma allowed us to achieve a significant positive...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2019-06-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/3065 |
| _version_ | 1797841436725477376 |
|---|---|
| author | L. M. Kogonia E. V. Markarova G. A. Stashuk M. M. Byakhova M. M. Akhmetov |
| author_facet | L. M. Kogonia E. V. Markarova G. A. Stashuk M. M. Byakhova M. M. Akhmetov |
| author_sort | L. M. Kogonia |
| collection | DOAJ |
| description | The article describes the experience in effective use of the second-generation EGFR II blocker in palliative target therapy of EGFRnegative lung adenocarcinoma. The use of afatinib in the fifth-line palliative therapy of EGFR-negative lung adenocarcinoma allowed us to achieve a significant positive response to therapy in the lungs and improve the patient’s quality of life. |
| first_indexed | 2024-04-09T16:30:47Z |
| format | Article |
| id | doaj.art-6f9b23185df142ee8550301a76df9a60 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:30:47Z |
| publishDate | 2019-06-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-6f9b23185df142ee8550301a76df9a602023-04-23T06:57:06ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-06-0101014214510.21518/2079-701X-2019-10-142-1452979Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinomaL. M. Kogonia0E. V. Markarova1G. A. Stashuk2M. M. Byakhova3M. M. Akhmetov4State Budgetary Healthcare Institution of the Moscow Region «Vladimirsky Moscow Regional Research Clinical Institute».State Budgetary Healthcare Institution of the Moscow Region «Vladimirsky Moscow Regional Research Clinical Institute».State Budgetary Healthcare Institution of the Moscow Region «Vladimirsky Moscow Regional Research Clinical Institute».State Budgetary Healthcare Institution of the Moscow Region «Vladimirsky Moscow Regional Research Clinical Institute».State Budgetary Healthcare Institution of the Moscow Region «Vladimirsky Moscow Regional Research Clinical Institute».The article describes the experience in effective use of the second-generation EGFR II blocker in palliative target therapy of EGFRnegative lung adenocarcinoma. The use of afatinib in the fifth-line palliative therapy of EGFR-negative lung adenocarcinoma allowed us to achieve a significant positive response to therapy in the lungs and improve the patient’s quality of life.https://www.med-sovet.pro/jour/article/view/3065lung canceradenocarcinomanon-small cell lung canceregfr mutationchemotherapytargeted therapyefficacyquality of lifeside effects |
| spellingShingle | L. M. Kogonia E. V. Markarova G. A. Stashuk M. M. Byakhova M. M. Akhmetov Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma Медицинский совет lung cancer adenocarcinoma non-small cell lung cancer egfr mutation chemotherapy targeted therapy efficacy quality of life side effects |
| title | Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
| title_full | Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
| title_fullStr | Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
| title_full_unstemmed | Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
| title_short | Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
| title_sort | clinical experience of effective use of palliative targeted therapy in a patient with egfr negative lung adenocarcinoma |
| topic | lung cancer adenocarcinoma non-small cell lung cancer egfr mutation chemotherapy targeted therapy efficacy quality of life side effects |
| url | https://www.med-sovet.pro/jour/article/view/3065 |
| work_keys_str_mv | AT lmkogonia clinicalexperienceofeffectiveuseofpalliativetargetedtherapyinapatientwithegfrnegativelungadenocarcinoma AT evmarkarova clinicalexperienceofeffectiveuseofpalliativetargetedtherapyinapatientwithegfrnegativelungadenocarcinoma AT gastashuk clinicalexperienceofeffectiveuseofpalliativetargetedtherapyinapatientwithegfrnegativelungadenocarcinoma AT mmbyakhova clinicalexperienceofeffectiveuseofpalliativetargetedtherapyinapatientwithegfrnegativelungadenocarcinoma AT mmakhmetov clinicalexperienceofeffectiveuseofpalliativetargetedtherapyinapatientwithegfrnegativelungadenocarcinoma |